625 related articles for article (PubMed ID: 31285549)
1. KIAA1429 acts as an oncogenic factor in breast cancer by regulating CDK1 in an N6-methyladenosine-independent manner.
Qian JY; Gao J; Sun X; Cao MD; Shi L; Xia TS; Zhou WB; Wang S; Ding Q; Wei JF
Oncogene; 2019 Aug; 38(33):6123-6141. PubMed ID: 31285549
[TBL] [Abstract][Full Text] [Related]
2. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.
Lan T; Li H; Zhang D; Xu L; Liu H; Hao X; Yan X; Liao H; Chen X; Xie K; Li J; Liao M; Huang J; Yuan K; Zeng Y; Wu H
Mol Cancer; 2019 Dec; 18(1):186. PubMed ID: 31856849
[TBL] [Abstract][Full Text] [Related]
3. N
Li Y; He L; Wang Y; Tan Y; Zhang F
Bioengineered; 2022 May; 13(5):11923-11932. PubMed ID: 35546050
[TBL] [Abstract][Full Text] [Related]
4. KIAA1429 regulates cell proliferation by targeting c-Jun messenger RNA directly in gastric cancer.
Miao R; Dai CC; Mei L; Xu J; Sun SW; Xing YL; Wu LS; Wang MH; Wei JF
J Cell Physiol; 2020 Oct; 235(10):7420-7432. PubMed ID: 32052427
[TBL] [Abstract][Full Text] [Related]
5. Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.
Zhang C; Sun Q; Zhang X; Qin N; Pu Z; Gu Y; Yan C; Zhu M; Dai J; Wang C; Li N; Jin G; Ma H; Hu Z; Zhang E; Tan F; Shen H
Cancer Commun (Lond); 2022 Jul; 42(7):609-626. PubMed ID: 35730068
[TBL] [Abstract][Full Text] [Related]
6. SMC1A regulated by KIAA1429 in m6A-independent manner promotes EMT progress in breast cancer.
Zhang X; Dai XY; Qian JY; Xu F; Wang ZW; Xia T; Zhou XJ; Li XX; Shi L; Wei JF; Ding Q
Mol Ther Nucleic Acids; 2022 Mar; 27():133-146. PubMed ID: 34976433
[TBL] [Abstract][Full Text] [Related]
7. circ_KIAA1429 accelerates hepatocellular carcinoma advancement through the mechanism of m
Wang M; Yang Y; Yang J; Yang J; Han S
Life Sci; 2020 Sep; 257():118082. PubMed ID: 32653519
[TBL] [Abstract][Full Text] [Related]
8. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
[TBL] [Abstract][Full Text] [Related]
9. m
Yang D; Chang S; Li F; Ma M; Yang J; Lv X; Huangfu L; Jia C
IUBMB Life; 2021 Nov; 73(11):1325-1333. PubMed ID: 34409730
[TBL] [Abstract][Full Text] [Related]
10. CircMETTL3, upregulated in a m6A-dependent manner, promotes breast cancer progression.
Li Z; Yang HY; Dai XY; Zhang X; Huang YZ; Shi L; Wei JF; Ding Q
Int J Biol Sci; 2021; 17(5):1178-1190. PubMed ID: 33867838
[TBL] [Abstract][Full Text] [Related]
11. KIAA1429 promotes tumorigenesis and gefitinib resistance in lung adenocarcinoma by activating the JNK/ MAPK pathway in an m
Lin X; Ye R; Li Z; Zhang B; Huang Y; Du J; Wang B; Meng H; Xian H; Yang X; Zhang X; Zhong Y; Huang Z
Drug Resist Updat; 2023 Jan; 66():100908. PubMed ID: 36493511
[TBL] [Abstract][Full Text] [Related]
12. m
Zhou Y; Pei Z; Maimaiti A; Zheng L; Zhu Z; Tian M; Zhou Z; Tan F; Pei Q; Li Y; Liu W
Cell Death Discov; 2022 Feb; 8(1):83. PubMed ID: 35217651
[TBL] [Abstract][Full Text] [Related]
13. KIAA1429 is a potential prognostic marker in colorectal cancer by promoting the proliferation via downregulating WEE1 expression in an m6A-independent manner.
Ma L; Lin Y; Sun SW; Xu J; Yu T; Chen WL; Zhang LH; Guo YC; Wang YW; Chen T; Wei JF; Zhu LJ
Oncogene; 2022 Jan; 41(5):692-703. PubMed ID: 34819634
[TBL] [Abstract][Full Text] [Related]
14. N6-methyladenine- induced LINC00667 promoted breast cancer progression through m6A/KIAA1429 positive feedback loop.
Ren S; Zhang Y; Yang X; Li X; Zheng Y; Liu Y; Zhang X
Bioengineered; 2022 May; 13(5):13462-13473. PubMed ID: 36700472
[TBL] [Abstract][Full Text] [Related]
15. Aberrations of m6A regulators are associated with tumorigenesis and metastasis in head and neck squamous cell carcinoma.
Arumugam P; George R; Jayaseelan VP
Arch Oral Biol; 2021 Feb; 122():105030. PubMed ID: 33383437
[TBL] [Abstract][Full Text] [Related]
16. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
17. KIAA1429 facilitates metastasis via m6A-YTHDC1-dependent RND3 down-regulation in hepatocellular carcinoma cells.
Shan M; Liu D; Sun L; Yang M; He M; Zhang Y; Xiang L; Lu L; He H; Niu D; Chen L; Li S; Chen A; He F; Wang Y; Lian J
Cancer Lett; 2024 Mar; 584():216598. PubMed ID: 38224863
[TBL] [Abstract][Full Text] [Related]
18. N
Tang B; Li M; Xu Y; Li X
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5037-5045. PubMed ID: 36326914
[TBL] [Abstract][Full Text] [Related]
19. Inhibin A contributes to the tumorigenesis of oral squamous cell carcinoma by KIAA1429-mediated m6A modification.
Chen X; Fan R
J Oral Pathol Med; 2024 Apr; 53(4):266-274. PubMed ID: 38531807
[TBL] [Abstract][Full Text] [Related]
20. KIAA1429/VIRMA promotes breast cancer progression by m
Li N; Zhu Z; Deng Y; Tang R; Hui H; Kang Y; Rana TM
EMBO Rep; 2023 Oct; 24(10):e55506. PubMed ID: 37705505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
